Nvidia’s China H200 Restart Sparks Trade Debate: Near-Term Catalyst or Overpriced Bet?

The recent pop in Nvidia shares is a direct response to two concrete developments. First, the stock gained 3% during trading on Monday after a Wall Street upgrade. More specifically, shares moved 1% higher on Wednesday following a Rosenblatt Securities upgrade. Second, and more crucially, CEO Jensen Huang announced the company is restarting H200 accelerator production for Chinese customers, signaling a tangible step toward resuming sales in that key market.

Rosenblatt's move was the primary catalyst for the mid-week gain. The firm raised its price target to $325 from $300 and maintained a Buy rating. Its bullish case is built on a staggering financial projection: more than $1 trillion in combined revenue from the Blackwell and Rubin product families between 2025 and 2027. This forecast, which also raised the fiscal 2028 revenue estimate to $550 billion, provides a powerful narrative for the stock's rally.

The immediate tactical question is whether this setup is sustainable. The stock's reaction is to a near-term catalyst-the China restart-and a long-term financial projection. Yet the entire setup hinges on execution and timing. The H200 restart is new news, but the company has faced significant delays and still expects no data center revenue from China in its current quarter guidance. The path to unlocking that trillion-dollar revenue stream remains fraught with regulatory hurdles and supply chain adjustments.

The Mechanics: China's Reopening and the $1 Trillion Bet

The tangible step of restarting H200 production is a clear catalyst, but it is a constrained one. CEO Jensen Huang announced the company is restarting our manufacturing for Chinese customers, a move that signals a shift from earlier weeks of limited approvals. Yet shipments remain firmly under U.S. control. Each H200 sale requires a government license, is subject to inspection, and triggers a 25% revenue share to the government. The total volume is also capped, with officials considering limits of 75,000 chips per customer and a potential total of 1 million processors. This is a partial reopening, not a full-scale return.

This operational reality contrasts sharply with the long-term financial projection. Rosenblatt's bullish case is built on a staggering forecast: more than $1 trillion in combined revenue from the Blackwell and Rubin product families between 2025 and 2027. However, this number is a specific bet on AI accelerators. It explicitly does not include the company's networking chips and the new processors made with technology from the Groq licensing deal. The $1 trillion figure is for a three-year window, not a perpetual revenue stream, and it excludes the significant revenue that could come from China.

That context is critical. China once represented about a quarter of Nvidia's revenue. Even a gradual reopening, starting with the H200, could meaningfully offset the current guidance that excludes any China data center revenue for the current quarter. The near-term opportunity is therefore twofold: the stock is pricing in a near-term catalyst (the restart) while the valuation is being supported by a long-term, high-stakes bet on global AI demand. The tactical setup hinges on whether the constrained China shipments can begin to materialize before the market prices in the full $1 trillion forecast.

The Setup: Valuation, Momentum, and Key Risks

The immediate risk/reward hinges on a stock priced for perfection. Nvidia trades at a forward P/E of nearly 48.5, but the key metric for this catalyst is the valuation multiple applied to Rosenblatt's projected fiscal 2028 earnings per share of $13. The firm's new $325 price target implies a multiple of 25 times that figure. That premium prices in the entire $1 trillion growth story, leaving little room for execution missteps on the China restart.

Recent momentum shows the setup is fragile. Despite the recent upgrade-driven pop, the stock is down 3% over the past five days and 4% over the past 20 days. This volatility indicates underlying sentiment is choppy and susceptible to any news that questions the China ramp or the long-term forecast. The stock remains far from its 52-week high, suggesting a lack of sustained conviction.

The primary near-term risk is execution. The company has secured licenses and restarted manufacturing, but converting that into revenue is a complex, regulated process. The key hurdles are securing sufficient licenses for the initial volume, managing the supply chain ramp under tight constraints, and ensuring shipments actually materialize before the market prices in the full $1 trillion forecast. As noted, shipments are subject to US inspection and a 25% duty, and officials are considering strict volume caps. Any delay or shortfall in the initial shipments could quickly deflate the current optimism and pressure the stock.